CD34 and myelodysplastic syndrome: In humans, decreased adult bone marrow osteoblast and osteoclast numbers have been associated with MDS development [284], while a significantly reduced ability of MDS-derived MSCs to support human CD34+ HSPC proliferation in long term in vitro cultures has also been reported [285].